U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed.

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

The drugs identified for negotiation in the second round include: Ozempic, Wegovy and other GPL-inhibitors are in high demand in the U.S. Due to that demand, Medicare covering them for diabetes ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

"Wegovy is still the household name ... The drugmaker could also explain how it plans to promote Zepbound to older Americans covered by Medicare, now that the U.S. government health program for people ...